Abstract: The present disclosure relates to thermo-stable/heat stable strain(s) of micro-organisms, obtaining such thermo-stable strains and incorporating them into food products. These strains are able to survive high temperatures for longer periods of time and thus food products containing such strains are therapeutically effective and beneficial for general health.
Abstract: The present disclosure relates to thermo-stable/heat stable strain(s) of micro-organisms, obtaining such thermo-stable strains and incorporating them into food products. These strains are able to survive high temperatures for longer periods of time and thus food products containing such strains are therapeutically effective and beneficial for general health.
Abstract: A voltage clamp circuit for reflecting a voltage at an input node includes a circuit for providing at least two currents at its output terminal, and at least two diodes each being connected to an output terminal of the circuit for providing at least two currents. The diodes also are connected to a line of a ground voltage and to the input node respectively. The circuit includes an alternative current path connected to an output terminal of the circuit for providing at least two currents and to a current sinking node. The voltage at the input node thus is reflected as the voltage between two output nodes when the voltage at the input node is lower than a clamping voltage and so that the voltage is fixed between the two output nodes to the clamping voltage when the voltage at the input node is higher than the clamping voltage.
Abstract: Growth medium are disclosed for use in fermenting a marine microorganism. The medium comprise Potassium, Calcium, Strontium, Borate and Fluoride at specific concentrations. Alternatively, the growth medium comprises cobalt at specified concentrations or comprises vitamin B12 at specified concentrations. Methods of producing certain desired compound by fermentation of a marine microorganism are also disclosed.
Type:
Grant
Filed:
September 24, 2007
Date of Patent:
March 24, 2015
Assignee:
Triphase Research and Development I Corp.
Abstract: Disclosed herein are compositions and methods for treating neoplastic diseases. Included are compositions and methods that are effective against multiple myeloma cells resistant to conventional and bortezomib treatment. Furthermore, combination treatment with two different proteosome inhibitors is shown to be synergistic for treating multiple myeloma.
Type:
Application
Filed:
March 25, 2014
Publication date:
November 27, 2014
Applicants:
Dana-Farber Cancer Institute, Inc., Triphase Research and Development I Corp.
Inventors:
Kenneth C. Anderson, Dharminder Chauhan, Michael A. Palladino
Abstract: Disclosed herein are compositions and methods for treating neoplastic diseases. Included are compositions and methods that are effective against multiple myeloma cells resistant to conventional and bortezomib treatment. Furthermore, combination treatment with two different proteosome inhibitors is shown to be synergistic for treating multiple myeloma.
Type:
Grant
Filed:
July 30, 2008
Date of Patent:
May 13, 2014
Assignees:
Triphase Research and Development I Corp., Dana-Farber Cancer Institute, Inc.
Inventors:
Kenneth C. Anderson, Dharminder Chauhan, Michael A. Palladino